FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Yu Chen

Research Profile

Living Beings

Disorders

Physiology

Virus Replication

Procedures

Anatomy

Tumor Cells, Cultured

Chemicals & Drugs

Concepts & Ideas

Time Factors

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Yuanhao Li; Yu Chen; Jeanette Dilley; Trini Arroyo; Derek Ko; Peter Working; De-Chao Yu
Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapy.
Jane Zhang; Nagarajan Ramesh; Yu Chen; Yuanhao Li; Jeanette Dilley; Peter Working; De-Chao Yu
Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
Theodore L DeWeese; H van der Poel; Shidong Li; Bahar Mikhak; R Drew; M Goemann; Ulrike M Hamper; R DeJong; Nicholas Detorie; Ronald Rodriguez; T Haulk; Angelo M DeMarzo; Steven Piantadosi; De-Chao Yu; Yu Chen; DR Henderson; Michael A Carducci; William G Nelson; Jonathan W Simons
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Yu Chen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2003: Yuanhao Li; Yu Chen; Jeanette Dilley; Trini Arroyo; Derek Ko; Peter Working; De-Chao Yu
Carcinoembryonic antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal cancer therapy.
Molecular cancer therapeutics 2003;2(10):1003-9.
2002: Jane Zhang; Nagarajan Ramesh; Yu Chen; Yuanhao Li; Jeanette Dilley; Peter Working; De-Chao Yu
Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel.
Cancer research 2002;62(13):3743-50.
2001: Theodore L DeWeese; H van der Poel; Shidong Li; Bahar Mikhak; R Drew; M Goemann; Ulrike M Hamper; R DeJong; Nicholas Detorie; Ronald Rodriguez; T Haulk; Angelo M DeMarzo; Steven Piantadosi; De-Chao Yu; Yu Chen; DR Henderson; Michael A Carducci; William G Nelson; Jonathan W Simons
A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.
Cancer research 2001;61(20):7464-72.
2001: Yuanhao Li; De-Chao Yu; Yu Chen; P Amin; H Zhang; Natalie Nguyen; DR Henderson
A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Cancer research 2001;61(17):6428-36.
2001: Yu Chen; Theodore L DeWeese; Jeanette Dilley; Y Zhang; Yuanhao Li; Nagarajan Ramesh; J Lee; R Pennathur-Das; J Radzyminski; J Wypych; D Brignetti; S Scott; J Stephens; D B Karpf; DR Henderson; De-Chao Yu
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.
Cancer research 2001;61(14):5453-60.
2001: De-Chao Yu; Yu Chen; Jeanette Dilley; Yuanhao Li; M Embry; H Zhang; Natalie Nguyen; P Amin; J Oh; DR Henderson
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel.
Cancer research 2001;61(2):517-25.
2000: Yu Chen; De-Chao Yu; D Charlton; DR Henderson
Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy.
Human gene therapy 2000;11(11):1553-67.
1999: De-Chao Yu; Yu Chen; M Seng; Jeanette Dilley; DR Henderson
The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts.
Cancer research 1999;59(17):4200-3.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.